112 related articles for article (PubMed ID: 16636258)
1. Increase in multiple sclerosis relapse rate following in vitro fertilization.
Laplaud DA; Leray E; Barrière P; Wiertlewski S; Moreau T
Neurology; 2006 Apr; 66(8):1280-1. PubMed ID: 16636258
[No Abstract] [Full Text] [Related]
2. [Increased risk of relapse in multiple sclerosis patients after ovarian stimulation for in vitro fertilization].
Laplaud DA; Lefrère F; Leray E; Barrière P; Wiertlewski S
Gynecol Obstet Fertil; 2007 Oct; 35(10):1047-50. PubMed ID: 17916439
[TBL] [Abstract][Full Text] [Related]
3. Increased MS relapse rate during assisted reproduction technique.
Hellwig K; Beste C; Brune N; Haghikia A; Müller T; Schimrigk S; Gold R
J Neurol; 2008 Apr; 255(4):592-3. PubMed ID: 18408881
[No Abstract] [Full Text] [Related]
4. Effects of interrupted immunomodulant therapy on the neurological state of multiple sclerosis patients.
Bencsik K; Fricska-Nagy Z; Rajda C; Füvesi J; Török M; Vécsei L; Csépány T; Mátyás K; Dobos E; Rózsa C; Semjén J
J Neurol Sci; 2007 Sep; 260(1-2):296-7. PubMed ID: 17475280
[No Abstract] [Full Text] [Related]
5. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
[TBL] [Abstract][Full Text] [Related]
6. Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosis.
Koch M; Mostert J; De Keyser J; Tremlett H; Filippini G
Ann Neurol; 2008 Jan; 63(1):125-6; author reply 126-7. PubMed ID: 17702024
[No Abstract] [Full Text] [Related]
7. Predicting beta-interferon failure in relapsing-remitting multiple sclerosis.
O'Rourke K; Walsh C; Antonelli G; Hutchinson M
Mult Scler; 2007 Apr; 13(3):336-42. PubMed ID: 17439902
[TBL] [Abstract][Full Text] [Related]
8. Assessing disability progression with the Multiple Sclerosis Functional Composite.
Rudick RA; Polman CH; Cohen JA; Walton MK; Miller AE; Confavreux C; Lublin FD; Hutchinson M; O'Connor PW; Schwid SR; Balcer LJ; Lynn F; Panzara MA; Sandrock AW
Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
[TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis.
Cocco E; Marchi P; Sardu C; Russo P; Paolillo A; Mascia M; Solla M; Frau J; Lorefice L; Massole S; Floris G; Marrosu M
Mult Scler; 2007 Sep; 13(8):975-80. PubMed ID: 17468439
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS.
Cohen JA; Rovaris M; Goodman AD; Ladkani D; Wynn D; Filippi M;
Neurology; 2007 Mar; 68(12):939-44. PubMed ID: 17372130
[TBL] [Abstract][Full Text] [Related]
11. Effect of relapses over early progression of disability in multiple sclerosis patients treated with beta-interferon.
Bosca I; Coret F; Valero C; Pascual AM; Magraner MJ; Landete L; Casanova B
Mult Scler; 2008 Jun; 14(5):636-9. PubMed ID: 18566027
[TBL] [Abstract][Full Text] [Related]
12. Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosis.
Stüve O; Leussink VI; Fröhlich R; Hemmer B; Hartung HP; Menge T; Kieseier BC
Arch Neurol; 2009 Feb; 66(2):259-61. PubMed ID: 19204165
[TBL] [Abstract][Full Text] [Related]
13. Paradoxically aggressive multiple sclerosis in the face of natalizumab therapy.
Berger JR
Mult Scler; 2008 Jun; 14(5):708-10. PubMed ID: 18566035
[TBL] [Abstract][Full Text] [Related]
14. Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis.
Zhao Y; Traboulsee A; Petkau AJ; Li D
Neurology; 2008 Mar; 70(13 Pt 2):1092-7. PubMed ID: 18003938
[TBL] [Abstract][Full Text] [Related]
15. Relapse management in multiple sclerosis.
Thrower BW
Neurologist; 2009 Jan; 15(1):1-5. PubMed ID: 19131851
[TBL] [Abstract][Full Text] [Related]
16. A case of Takotsubo syndrome during a multiple sclerosis brainstem relapse.
Prestipino E; Squitieri M; Razzolini L; Pastò L; Forleo P; Amato MP
Mult Scler Relat Disord; 2018 Aug; 24():1-2. PubMed ID: 29804030
[TBL] [Abstract][Full Text] [Related]
17. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
[TBL] [Abstract][Full Text] [Related]
18. [Ulcerative colitis in a female patient with multiple sclerosis receiving treatment with interferon].
Palao-Duarte S; Corral-Corral I; Zarza B; Costa-Frossard L
Rev Neurol; 2005 Sep 1-15; 41(5):319-20. PubMed ID: 16138294
[No Abstract] [Full Text] [Related]
19. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
[TBL] [Abstract][Full Text] [Related]
20. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.
Tremlett H; van der Mei IA; Pittas F; Blizzard L; Paley G; Mesaros D; Woodbaker R; Nunez M; Dwyer T; Taylor BV; Ponsonby AL
Neuroepidemiology; 2008; 31(4):271-9. PubMed ID: 18971584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
